Medical and Science
Eminent University of Sydney virologist named NSW Scientist of the Year
Medical News: World-renowned virologist Professor Edward Holmes from The University of Sydney has been named 2020 NSW Scientist of the Year.
Premier Gladys Berejiklian said Professor Holmes was one of 11 leading researchers, innovators and educators to be honoured at the 2020 Premier’s Prizes for Science & Engineering, held at Government House tonight.
Professor Holmes, who will receive a prize of $60,000, was honoured for his research on the emergence, evolution and spread of viruses. His particular focus is on how viruses can jump species boundaries, with the potential to cause disease epidemics and pandemics.
Ms Berejiklian said that the prizes were an opportunity to celebrate the extraordinary contribution that NSW scientists and engineers make to our everyday lives.
“In a year of unparalleled challenges, our state has placed its trust in science. The NSW Government will continue to support our finest scientists, engineers and educators, not only to manage the issues we face, but also to ensure that their innovation and expertise is integral to building a stronger, smarter, more agile economy post-COVID-19,” Ms Berejiklian said.
Professor Holmes’ work has led to fundamental insights into the origin and spread of numerous viruses, including hepatitis C, HIV, influenza, West Nile, dengue, Zika and Ebola.
Most recently, Professor Holmes was involved in key research that showed that SARS-CoV-2 was the causative agent of COVID-19. In January 2020, he was the first person to publicly release the genome sequence of the virus, enabling the rapid development of diagnostic tests.
He followed this with fundamental research into the animal origins of SARS-CoV-2, helping to demonstrate the presence of related viruses in bats and pangolins, and showing that coronaviruses have an ability to jump species boundaries and emerge in new hosts.
“It’s a tremendous honour to receive this award, which is built on the hard work of my team and collaborators over many years,” Professor Holmes said.
“My work has consistently warned us of the potential of virus pandemics. I’m so thankful and proud to be living in a state and country in which the science has been listened to and used to help build such an effective response to COVID-19.”
Minister for Planning and Public Spaces Rob Stokes presented the prizes on behalf of the Premier, stating that this year’s winners highlighted the ongoing relevance and importance of research and education in our daily lives.
“It’s a great honour to present these awards and celebrate the work of these extraordinary people,” Mr Stokes said.
“They’ve played key roles across a range of fields and are often the unsung heroes of our state. The awards are a reminder of the incredible talent we have here in NSW in cutting edge technologies that help safeguard our future.”
NSW Chief Scientist & Engineer Professor Hugh Durrant-Whyte said “Our Scientist of the Year, Professor Edward Holmes, is a global authority in virology and the significance of his work in the early identification of the devastating potential of the coronavirus cannot be overstated.”
“My sincere congratulations to all our winners – noting that this year, for the first time, female recipients outnumber males – and my thanks to them for their outstanding contribution to science, engineering and education in NSW.”
The NSW Premier’s Prizes for Science & Engineering is an annual event held by the NSW Government to celebrate the achievements of the state’s finest scientists, engineers and educators. It is held at Government House in the presence of its patron, Her Excellency, the Honourable Margaret Beazley AC QC, Governor of New South Wales.
Category Prize Winners
Category 1: Excellence in Mathematics, Earth Sciences, Chemistry or Physics
Winner: Distinguished Professor Suzanne O’Reilly, Macquarie University
Category 2: Excellence in Biological Sciences (Ecology, environmental, agricultural and organismal)
Winner: Professor Ian Wright, Macquarie University
Category 3: Excellence in Medical Biological Sciences (Cell and molecular, medical, veterinary and genetics)
Joint winner: Distinguished Professor Antoine van Oijen, the University of Wollongong
Category 3: Excellence in Medical Biological Sciences (Cell and molecular, medical, veterinary and genetics)
Joint winner: Professor Merlin Crossley, UNSW Sydney
Category 4: Excellence in Engineering or Information and Communications Technologies
Winner: Distinguished Professor Zaiping Guo, the University of Wollongong
Category 5: NSW Early Career Researcher of the Year (Biological Sciences)
Winner: Dr Rachael Gallagher, Macquarie University
Category 6: NSW Early Career Researcher of the Year (Physical Sciences)
Winner: Dr Jelena Rnjak-Kovacina, UNSW Sydney
Category 7: Leadership in Innovation in NSW
Winner: Professor Ewa Goldys, UNSW Sydney
Category 8: Innovation in NSW Public Sector Science and Engineering
Winner: Dr David Hopkins, NSW Department of Primary Industries
Category 9: Innovation in Science, Technology, Engineering or Mathematics Teaching in NSW
Winner: Ms Sophie Poisel, Emanuel School
News & Trends - Pharmaceuticals
Novo Nordisk and Lilly’s GLP-1 agonists show promise in type 1 diabetes
Pharma News: GLP-1 receptor agonists lead to significant weight loss and improve blood sugar control in individuals with type 1 […]
MoreNews & Trends - MedTech & Diagnostics
Health Department’s proposed reporting rules face industry pushback over costs and confidentiality
MedTech News: The Department of Health has unveiled stakeholder feedback on the reporting requirements for the Prescribed List (PL), sparking […]
MoreNews & Trends - MedTech & Diagnostics
Threat to innovation: Health Department’s PL reforms spark industry backlash
MedTech News: The Department of Health has unveiled stakeholder feedback on the alignment of charges for supplying medical devices with […]
MoreNews & Trends - Pharmaceuticals
Novartis’ radioligand therapy shows ‘remarkable’ results in Australian trial for advanced prostate cancer
Pharma News: Novartis’ radioligand therapy (RLT), hailed as a game-changer for late-stage prostate cancer, is now showing promise for dramatically […]
More